Abstract
This cross-sectional study compares the duration of postapproval trials with that of the pivotal trials used as the basis for the US Food and Drug Administration’s (FDA’s) approval for all indications receiving accelerated approval from 2009-2018.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Clinical Trials as Topic / statistics & numerical data*
-
Drug Approval / statistics & numerical data*
-
Drug Industry / methods
-
Humans
-
Product Surveillance, Postmarketing / statistics & numerical data
-
Product Surveillance, Postmarketing / trends*
-
United States
-
United States Food and Drug Administration